Skip to main content

Clonixin use while Breastfeeding

Medically reviewed by Drugs.com. Last updated on Oct 21, 2024.

Clonixin Levels and Effects while Breastfeeding

Summary of Use during Lactation

Clonixin is not approved for marketing in the United States by the U.S. Food and Drug Administration but is available in other countries. No information is available on the use of clonixin during breastfeeding. An alternate drug is preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Clonixin

CAS Registry Number

17737-65-4

Drug Class

Breast Feeding

Lactation

Milk, Human

Anti-Inflammatory Agents, Non-Steroidal

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.